Childhood Cancer

You are here

A comprehensive public resource for fusion-negative sarcoma sequencing data

Institution: 
University of California San Francisco
Researcher(s): 
Alejandro Sweet-Cordero, MD & Richard Gorlick, MD
Grant Type: 
Crazy 8 Initiative
Year Awarded: 
2019
Type of Childhood Cancer: 
General Pediatric Cancer
Project Description: 

Fusion-negative sarcomas are a diverse and understudied subset of pediatric cancers. The most prevalent are embryonal rhabdomyosarcoma (ERMS) and osteosarcoma (OS). Osteosarcoma is characterized by an abnormal genome with many alterations, most of which are called “copy number gains” or “copy number losses.” In a normal genome, there are only two copies of every gene. However, in OS many genes have more than 4 copies, sometimes even 10 or more copies. ERMS is characterized by mutations in several targetable genes, commonly those in an altered pathway called the RAS pathway, as well as significant copy number gains. To date, several different groups have performed comprehensive sequencing of OS and ERMS. However, a significant barrier to progress in studying these tumors and in the design of novel precision medicine clinical trials is that it is not currently possible to visualize all of this data in one place because it is located in individual labs and in many separate databases. For example, it is quite difficult to evaluate how common a given copy number alteration in a specific gene is in either OS or ERMS. This inability to compare large data for these sarcomas limits our ability to identify recurrent or co-occurring alterations that might help us design better clinical trials. To address this significant problem, we propose to build a public resource that will allow for visualization and data sharing of all available ERMS and OS sequencing data.

Co-funded by: 
Northwestern Mutual Foundation